These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419 [TBL] [Abstract][Full Text] [Related]
3. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Davì G; Averna M; Catalano I; Barbagallo C; Ganci A; Notarbartolo A; Ciabattoni G; Patrono C Circulation; 1992 May; 85(5):1792-8. PubMed ID: 1572035 [TBL] [Abstract][Full Text] [Related]
4. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Vejar M; Fragasso G; Hackett D; Lipkin DP; Maseri A; Born GV; Ciabattoni G; Patrono C Thromb Haemost; 1990 Apr; 63(2):163-8. PubMed ID: 2363117 [TBL] [Abstract][Full Text] [Related]
6. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286 [TBL] [Abstract][Full Text] [Related]
7. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644 [TBL] [Abstract][Full Text] [Related]
8. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Fitzgerald DJ; Wright F; FitzGerald GA Circ Res; 1989 Jul; 65(1):83-94. PubMed ID: 2500270 [TBL] [Abstract][Full Text] [Related]
9. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969 [TBL] [Abstract][Full Text] [Related]
10. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Lupinetti MD; Sheller JR; Catella F; Fitzgerald GA Am Rev Respir Dis; 1989 Oct; 140(4):932-5. PubMed ID: 2508524 [TBL] [Abstract][Full Text] [Related]
14. Significance of urinary 11-dehydro-thromboxane B Simeone P; Boccatonda A; Liani R; Santilli F Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676 [TBL] [Abstract][Full Text] [Related]
15. Role of platelet and vascular eicosanoids in the pathophysiology of ischemic heart disease. Chierchia S; Patrono C Fed Proc; 1987 Jan; 46(1):81-8. PubMed ID: 3542579 [TBL] [Abstract][Full Text] [Related]
16. Biosynthesis and pharmacological modulation of thromboxane in humans. Patrono C Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814 [TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173 [TBL] [Abstract][Full Text] [Related]
18. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573 [TBL] [Abstract][Full Text] [Related]
20. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes. Neri Serneri GG; Gensini GF; Poggesi L; Modesti PA; Rostagno C; Boddi M; Gori AM; Martini F; Ieri A; Margheri M Coron Artery Dis; 1994 Feb; 5(2):137-45. PubMed ID: 8180744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]